← The Wire
CRBPNasdaq
Corbus Pharmaceuticals Holdings, Inc.
Pharmaceutical Preparations · DE · CIK 1595097
Corbus Pharmaceuticals develops new therapies for oncology and obesity
red 8-K · 90d🔥 High media attention
$152M
Market cap
$8.98
Last close
+2.8%
1D
+8.1%
5D
418K
Volume
Price · last 39 sessions-14.6%
May 4L $7.38 · H $12.15Jun 29
295
Total filings
May 26, 2026
Last filing
12/31
Fiscal year end
8-KReg FD Disclosure · Company UpdateMay 26, 20268-KExecutive Change · Material AgreementMay 21, 20268-KExecutive Change · Shareholder VoteMay 14, 202610-Q10-QMay 12, 20268-KResults of Operations · Reg FD DisclosureMay 12, 2026DEFA14ADEFA14AApr 16, 20268-KExecutive ChangeApr 16, 20268-KReg FD Disclosure · Company UpdateApr 14, 20268-KExecutive Change · Reg FD DisclosureApr 7, 2026DEFA14ADEFA14AApr 2, 2026DEF 14ADEF 14AApr 2, 202610-K10-KMar 9, 20268-KResults of Operations · Reg FD DisclosureMar 9, 20268-KReg FD DisclosureFeb 25, 20268-KReg FD DisclosureJan 12, 20268-KExecutive ChangeDec 18, 20258-KReg FD Disclosure · Company UpdateDec 11, 202510-Q10-QNov 12, 20258-KResults of Operations · Reg FD DisclosureNov 12, 20258-KMaterial Agreement · Reg FD DisclosureNov 3, 2025424B5424B5Nov 3, 20258-KCompany UpdateOct 30, 2025424B5424B5Oct 30, 20258-KReg FD Disclosure · Company UpdateOct 20, 20258-KReg FD Disclosure · Company UpdateSep 16, 202510-Q10-QAug 5, 20258-KResults of Operations · Reg FD DisclosureAug 5, 20258-KShareholder Vote · Company UpdateMay 19, 202510-Q10-QMay 6, 20258-KResults of Operations · Reg FD DisclosureMay 6, 2025DEFA14ADEFA14AApr 1, 2025DEF 14ADEF 14AApr 1, 20258-KExecutive ChangeMar 21, 20258-KExecutive ChangeMar 18, 202510-K10-KMar 11, 20258-KResults of Operations · Reg FD DisclosureMar 11, 20258-KReg FD Disclosure · Company UpdateFeb 14, 20258-KReg FD Disclosure · Company UpdateDec 3, 20248-KCompany UpdateNov 15, 2024SC 13GSCHEDULE 13GNov 14, 2024SC 13GSC 13GNov 8, 202410-Q10-QNov 7, 20248-KResults of Operations · Reg FD DisclosureNov 7, 20248-KReg FD Disclosure · Company UpdateNov 4, 2024SC 13GSC 13GOct 22, 2024SC 13GSC 13GOct 11, 20248-KCompany UpdateSep 3, 20248-KExecutive Change · Reg FD DisclosureAug 20, 20248-KReg FD DisclosureAug 6, 202410-Q10-QAug 6, 20248-KResults of Operations · Reg FD DisclosureAug 6, 20248-KCompany UpdateJun 17, 20248-KReg FD Disclosure · Company UpdateJun 3, 20248-KExecutive Change · Shareholder VoteMay 20, 20248-KCompany UpdateMay 9, 202410-Q10-QMay 7, 20248-KResults of Operations · Reg FD DisclosureMay 7, 2024DEFA14ADEFA14AApr 10, 20248-KExecutive ChangeApr 10, 2024DEFA14ADEFA14AApr 2, 2024DEF 14ADEF 14AApr 2, 20248-KCompany UpdateMar 20, 202410-K/A10-K/AMar 20, 202410-K10-KMar 12, 20248-KResults of Operations · Reg FD DisclosureMar 12, 2024SC 13GSC 13GFeb 28, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GFeb 14, 2024SC 13GCORBUS PHARMACEUTICALS HOLDINGS, INC.Feb 12, 2024SC 13GSC 13GFeb 12, 2024SC 13GSC 13GFeb 9, 20248-KExecutive ChangeFeb 6, 2024SC 13GSC 13GFeb 5, 2024SC 13GSC 13GFeb 5, 20248-KReg FD DisclosureFeb 5, 20248-K/ACompany UpdateFeb 2, 20248-KMaterial Agreement · Reg FD DisclosureFeb 1, 2024424B5424B5Feb 1, 20248-KCompany UpdateJan 31, 2024424B5424B5Jan 31, 2024
Insider Activity
In the 90 days to Mar 2, 2026: 5 sold $592K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Smethurst DominicChief Medical Officer | Sell | 6,097 | $8.30 | $51K |
| Feb 17, 2026 | Hodgson IanChief Operating Officer | Sell | 847 | $7.38 | $6K |
| Feb 13, 2026 | Cohen YuvalChief Executive Officer | Sell | 13,871 | $7.78 | $108K |
| Feb 13, 2026 | Moran Sean F.Chief Financial Officer | Sell | 4,701 | $7.78 | $37K |
| Feb 3, 2026 | Smethurst DominicChief Medical Officer | Sell | 3,285 | $8.09 | $27K |
| Feb 3, 2026 | Hodgson IanChief Operating Officer | Sell | 2,415 | $8.09 | $20K |
| Dec 11, 2025 | Chen BihuaTenPercentOwner | Sell | 30,029 | $11.46 | $344K |
| Oct 27, 2025 | Cohen YuvalChief Executive Officer | Sell | 8,973 | $17.14 | $154K |
| Oct 24, 2025 | Cohen YuvalChief Executive Officer | Sell | 18,660 | $17.01 | $317K |
| Oct 24, 2025 | Moran Sean F.Chief Financial Officer | Sell | 12,981 | $17.02 | $221K |
| Oct 20, 2025 | Altmeyer AnneDirector | Sell | 1,060 | $20.50 | $22K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 14 reputable articles.
MarketWatchCorbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day13h agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors5d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains12d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock rises Monday, still underperforms market14d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock rises Thursday, still underperforms market18d agoMarketWatchCorbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains20d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance